DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
DarioHealth Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.49−0.33 (-6.85%)
Close on Oct 19, 2026
- Market cap
- $41.95M
- P/E (TTM)
- 1.1
- Dividend yield
- –
DarioHealth statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | DarioHealth | Industry median |
|---|---|---|
| Market Cap | $44.00M | $230.55M |
| Enterprise Value | $61.10M | $202.97M |
| PE Ratio | 1.15 | 33.40 |
| PS Ratio | 2.10 | 3.11 |
| PB Ratio | 0.80 | 3.14 |
Enterprise value
| Measure | DarioHealth | Industry median |
|---|---|---|
| EV / Sales | 2.91 | 2.92 |
Income (trailing twelve months)
| Measure | DarioHealth | Industry median |
|---|---|---|
| Revenue | $21.00M | $102.39M |
| Gross Profit | $12.21M | $60.36M |
| Operating Income | -$31.83M | -$4.31M |
| Pretax Income | -$35.20M | -$2.26M |
| Net Income | -$35.67M | -$6.57M |
| EBITDA | -$31.83M | -$1.98M |
| EPS (Diluted) | $3.92 | -$0.07 |
Margins
| Measure | DarioHealth | Industry median |
|---|---|---|
| Gross Margin | 58.2% | 55.1% |
| Operating Margin | -151.6% | -6.04% |
| Pretax Margin | -167.6% | -4.11% |
| Profit Margin | -169.9% | -10.5% |
| EBITDA Margin | -151.6% | -2.67% |
| FCF Margin | -121.3% | -0.30% |
Returns
| Measure | DarioHealth | Industry median |
|---|---|---|
| Return on Equity (ROE) | -59.9% | -19.2% |
| Return on Assets (ROA) | -34.8% | -13.3% |
| Return on Invested Capital (ROIC) | -34.8% | -4.11% |
| Return on Capital Employed (ROCE) | -36.6% | -9.07% |
Growth
| Measure | DarioHealth | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -22.6% | 8.85% |
| Revenue Growth (3Y CAGR) | -6.84% | 7.08% |
| Revenue Growth (5Y CAGR) | 24.2% | 11.8% |
| EPS Growth (3Y CAGR) | 58.5% | 3.06% |
| EPS Growth (5Y CAGR) | 20.3% | 7.64% |
Balance sheet
| Measure | DarioHealth | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $13.96M | $37.33M |
| Total Debt | $31.06M | $72.66M |
| Net Cash (Debt) | -$17.10M | $3.92M |
| Net Cash Per Share | -$1.75 | $0.28 |
| Equity (Book Value) | $55.09M | $57.36M |
| Book Value Per Share | $5.62 | $2.81 |
| Tangible Book Value | -$17.34M | $10.71M |
| Working Capital | $12.55M | $54.64M |
Financial position
| Measure | DarioHealth | Industry median |
|---|---|---|
| Current Ratio | 2.31 | 2.50 |
| Quick Ratio | 1.46 | 1.54 |
| Debt / Equity | 0.56 | 0.38 |
| Interest Coverage | -7.03 | -1.81 |
Cash flow (trailing twelve months)
| Measure | DarioHealth | Industry median |
|---|---|---|
| Operating Cash Flow | -$25.35M | -$653.46K |
| Capital Expenditures | -$136.00K | -$3.69M |
| Free Cash Flow | -$25.48M | -$835.02K |
| FCF Per Share | -$2.60 | -$0.02 |
Efficiency
| Measure | DarioHealth | Industry median |
|---|---|---|
| Asset Turnover | 0.20 | 0.59 |
| Inventory Turnover | 2.11 | 2.21 |
| Revenue Per Employee | $131.24K | $322.57K |
| Profits Per Employee | -$222.94K | -$51.88K |
| Employee Count | 160 | 185 |
Dividends and yields
| Measure | DarioHealth | Industry median |
|---|---|---|
| Earnings Yield | -81.1% | -6.91% |
| FCF Yield | -57.9% | -0.56% |
Shares
| Measure | DarioHealth | Industry median |
|---|---|---|
| Shares Outstanding | 9,799,480 | 44,856,700 |
| Shares Change (YoY) | 149.4% | 3.35% |
| Shares Change (QoQ) | 0.59% | 0.27% |
| Float | 8,454,410 | 37,097,900 |
| Shares Held by Insiders | 13.7% | 10.6% |
| Shares Held by Institutions | 15.0% | 63.5% |
Taxes
| Measure | DarioHealth | Industry median |
|---|---|---|
| Income Tax | $468.00K | $1.52M |
Scores
| Measure | DarioHealth | Industry median |
|---|---|---|
| Graham Number | $22.27 | $34.37 |
| Graham Upside | 395.9% | -57.7% |
| Altman Z-Score | -6.87 | 1.95 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from DarioHealth's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.